Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-19

Clinical Trial Update: Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel, ifosfamide, and cisplatin for metastatic testicular germ cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • IFOSFAMIDE (IFOSFAMIDE)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Medical Research Council | Conditions: Testicular Germ Cell Tumor | Phase 2 | Status: COMPLETED